Carl Figdor

University of Twente

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Rob De Boer

Utrecht University

NETHERLANDS

View details

Niven Mehra

Radboud University Medical Center

NETHERLANDS

View details

Antoine A. Khalil

Assistant Professor/PhD

UMC Utrecht

NETHERLANDS

View details

Bettina Weigelin

W2 Professor

University of Tübingen

GERMANY

View details

Willem Joost Lesterhuis

University of Western Australia

AUSTRALIA

View details

Martijn Verdoes

Associate Professor

Radboud Universitair Medisch Centrum

NETHERLANDS

View details

Paul Kouwer

AssociateProf.

Radboud Universiteit Nijmegen

NETHERLANDS

View details

Paul N. Span

Radboud University Medical Center

NETHERLANDS

View details

Johannes Textor

Radboud University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carl Figdor

Research Interests

Explore related searches

Contact this professor

Articles (9)

ImmuNet: a segmentation-free machine learning pipeline for immune landscape phenotyping in tumors by multiplex imaging

Reprogramming the melanoma and immunosuppressive myeloid cells with esomeprazole-loaded PLGA nanoparticles

Semi‐Flexible Immunobrushes Facilitate Effective and Selective Expansion of Antigen‐Specific T Cells

In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome

Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination

Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome

Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity

A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery

Collective invasion induced by an autocrine purinergic loop through connexin-43 hemichannels

Collaborators (9)

Rob De Boer

Niven Mehra

Antoine A. Khalil

Bettina Weigelin

Willem Joost Lesterhuis

Martijn Verdoes

Paul Kouwer

Paul N. Span

Johannes Textor

Make your next move.